Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
iRhythm Technologies, Inc. (IRTC) to participate in 42nd Annual J.P. Morgan Healthcare Conference, with management presenting on January 8, 2024. The presentation will be available via live and archived webcast on the company’s investor website.
SAN FRANCISCO, Dec. 26, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
iRhythm’s management is scheduled to present on Monday, January 8, 2024, at 4:30 p.m. Pacific Time/7:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
(919) 452-5430
investors@irhythmtech.com
Media Contact
Saige Smith
(262) 289-7065
irhythm@highwirepr.com
iRhythm Technologies, Inc.’s ticker symbol is IRTC.
iRhythm Technologies, Inc. will be presenting on Monday, January 8, 2024, at 4:30 p.m. Pacific Time/7:30 p.m. Eastern Time.
Interested parties can access the live and archived webcast of iRhythm Technologies, Inc.’s presentation on the ‘Events & Presentations’ section of the company’s investor website at investors.irhythmtech.com.
NASDAQ:IRTC
IRTC Rankings
#4270 Ranked by Stock Gains
IRTC Latest News
IRTC Stock Data
Surgical and Medical Instrument Manufacturing
Manufacturing
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
San Francisco
About IRTC
irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
